# A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

> **NCT06868082** · PHASE1 · COMPLETED · sponsor: **Uniquity One (UNI)** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Solrikitug
- **BIOLOGICAL:** Solrikitug

## Key facts

- **NCT ID:** NCT06868082
- **Lead sponsor:** Uniquity One (UNI)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-20
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06868082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06868082, "A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06868082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*